Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EHC 
Encompass Health Corp (EHC)
Today’s top pick
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: EHC (4-star) is a STRONG-BUY. BUY since 9 days. Profits (2.69%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $135.75
1 Year Target Price $135.75
| 10 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 56.07% | Avg. Invested days 95 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.43B USD | Price to earnings Ratio 23.73 | 1Y Target Price 135.75 |
Price to earnings Ratio 23.73 | 1Y Target Price 135.75 | ||
Volume (30-day avg) 12 | Beta 0.74 | 52 Weeks Range 87.58 - 124.67 | Updated Date 08/29/2025 |
52 Weeks Range 87.58 - 124.67 | Updated Date 08/29/2025 | ||
Dividends yield (FY) 0.55% | Basic EPS (TTM) 5.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-04 | When After Market | Estimate 1.21 | Actual 1.4 |
Profitability
Profit Margin 9.22% | Operating Margin (TTM) 17.77% |
Management Effectiveness
Return on Assets (TTM) 9.18% | Return on Equity (TTM) 24.72% |
Valuation
Trailing PE 23.73 | Forward PE 25.13 | Enterprise Value 15020956566 | Price to Sales(TTM) 2.19 |
Enterprise Value 15020956566 | Price to Sales(TTM) 2.19 | ||
Enterprise Value to Revenue 2.65 | Enterprise Value to EBITDA 11.5 | Shares Outstanding 100724000 | Shares Floating 99222036 |
Shares Outstanding 100724000 | Shares Floating 99222036 | ||
Percent Insiders 1.41 | Percent Institutions 96.18 |
Upturn AI SWOT
Encompass Health Corp
Company Overview
History and Background
Encompass Health Corp. was founded in 1984 as HealthSouth Rehabilitation Corporation. It evolved to become a leading provider of post-acute healthcare services. The company rebranded as Encompass Health in 2018 to reflect its focus on integrated healthcare solutions.
Core Business Areas
- Inpatient Rehabilitation: Provides comprehensive rehabilitation services through a network of inpatient rehabilitation hospitals. These hospitals offer intensive therapy programs for patients recovering from stroke, spinal cord injury, brain injury, amputation, and other complex conditions.
- Home Health: Delivers home-based healthcare services, including skilled nursing, therapy, and personal care, to patients in their homes.
Leadership and Structure
Mark Tarr is the CEO of Encompass Health Corp. The company has a structured leadership team overseeing hospital operations, home health services, finance, and other key functions. The organizational structure includes regional and divisional management to oversee individual facilities and service lines.
Top Products and Market Share
Key Offerings
- Inpatient Rehabilitation Services: Comprehensive inpatient rehabilitation programs for patients recovering from debilitating illnesses and injuries. Encompass Health operates a large network of rehabilitation hospitals. Market share data suggests Encompass Health is a leader in this space. Competitors include Select Medical (SEM), Kindred Healthcare, and numerous regional providers.
- Home Health Services: Skilled nursing, therapy, and personal care services delivered in patients' homes. The market for home health services is competitive, with LHC Group (LHCG) , Amedisys (AMED), and Brookdale Senior Living (BKD) are key competitors.
Market Dynamics
Industry Overview
The post-acute healthcare market is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The industry is subject to regulatory changes and reimbursement pressures.
Positioning
Encompass Health is a leading provider of inpatient rehabilitation and home health services. Its competitive advantages include a large network of facilities, strong brand recognition, and expertise in providing specialized rehabilitation services.
Total Addressable Market (TAM)
The total addressable market for post-acute care is estimated to be in the hundreds of billions of dollars annually. Encompass Health holds a significant position, benefiting from demographic trends and the increasing demand for rehabilitation and home health services.
Upturn SWOT Analysis
Strengths
- Large and established network of inpatient rehabilitation hospitals
- Strong brand recognition in the rehabilitation industry
- Expertise in providing specialized rehabilitation services
- Integrated healthcare delivery model
- Financial Performance
Weaknesses
- Exposure to regulatory changes and reimbursement pressures
- High labor costs in the healthcare industry
- Geographic concentration in certain markets
- Dependence on referrals from hospitals and physicians
Opportunities
- Expanding the network of inpatient rehabilitation hospitals
- Growing the home health business through acquisitions and organic growth
- Developing new rehabilitation programs and services
- Leveraging technology to improve patient outcomes and efficiency
- Strategic partnerships
Threats
- Increased competition from other post-acute care providers
- Changes in healthcare reimbursement policies
- Rising labor costs and shortages of healthcare professionals
- Economic downturns that could reduce demand for healthcare services
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- Select Medical (SEM)
- LHC Group (LHCG)
- Amedisys (AMED)
Competitive Landscape
Encompass Health competes with other large post-acute care providers, as well as regional and local players. The company's advantages include its large network, strong brand, and expertise in specialized rehabilitation services. However, it faces challenges from regulatory changes, reimbursement pressures, and rising labor costs.
Major Acquisitions
Acquired Company Name
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expand service offerings in a key geographic market, increasing market share and access to new patients.
Growth Trajectory and Initiatives
Historical Growth: Encompass Health has experienced steady growth in recent years, driven by acquisitions and organic expansion. The company has focused on expanding its network of inpatient rehabilitation hospitals and growing its home health business.
Future Projections: Analyst estimates suggest continued growth for Encompass Health, driven by demographic trends and the increasing demand for post-acute care services.
Recent Initiatives: Recent initiatives include expanding telehealth capabilities, developing specialized rehabilitation programs, and investing in technology to improve patient outcomes and efficiency.
Summary
Encompass Health is a leading player in the post-acute care market, driven by a robust inpatient rehabilitation segment. Its competitive advantages include a large network and specialized services. The company faces regulatory challenges and rising labor costs. However, strategic initiatives and continued growth projections position Encompass Health favorably for the future.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share data is estimated and may vary. Financial data is as of the last available reporting period.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Encompass Health Corp
Exchange NYSE | Headquaters Birmingham, AL, United States | ||
IPO Launch date 1986-09-30 | CEO, President & Director Mr. Mark J. Tarr | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 28678 | Website https://www.encompasshealth.com |
Full time employees 28678 | Website https://www.encompasshealth.com | ||
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.